“…The previously described lead optimization work was strongly focused on KOR affinity and peptide stability optimization. To ensure that while improving activity, selectivity for KOR was not lost, we investigated selected key milestone molecules (1,6,23,26,39,44,48), where strong structural changes were made, for their receptor selectivity. The selectivity profile of dynA (1− 17) and selected peptides, e.g., 1, 6, 23, 26, 39, 44, 48 at other opiate receptors (Table 3) indicated that improvements in KOR affinity paralleled improvements in KOR selectivity relative to MOR, DOR, and NOP.…”